Skip to main content

Table 1 Baseline demographic data; Mean (Standard deviation (SD)), number (n) or percentage (%) for the total for all of group 1 and unblinded data for the two randomised arms; uACR/uPCR = urinary albumin/protein:creatinine ratio. eGFR = Estimated glomerular filtration rate; CRP = C-Reactive Protein. 6MWT = Six-minute walk test. MLHF = Minnesota Living and Heart Failure Questionnaire. Electrocardiogram (ECG): N = Within normal limits; NCS = Abnormal and not clinically significant; ACS = Abnormal and clinically significant. FDI = Ferric Derisomaltose

From: A multicentre prospective double blinded randomised controlled trial of intravenous iron (ferric Derisomaltose (FDI)) in Iron deficient but not anaemic patients with chronic kidney disease on functional status

Group and number of participants

FDI or Placebo

n = 54

CKD, no anaemia but iron deficiency

FDI

n = 26

Placebo

N = 28

Age (years) (SD)

59.6 (11.7)

61.6 (10.1)

57.8 (12.9)

Range

32–78

37–78

32–78

Sex

 Male

26 (49%)

11 (42.3%)

15 (53.6%)

 Female

27 (51%)

14 (53.8%)

13 (46.4%)

Unknown

1

1

0

Ethnicity

 White

42 (78%)

19 (73.1%)

23 (82.1%)

 Asian

3 (5%)

1 (3.8%)

2 (7.1%)

 Black

7 (13%)

4 (15.4%)

3 (10.7%)

 Mixed Race

1 (2%)

1 (3.8%)

0 (0%)

 Unknown/other

1 (2%)

1 (3.8%)

0 (0%)

Smoker

 Yes; current

5 (9%)

1 (3.8%)

4 (14.3%)

 Yes; previous

17 (32%)

8 (30.8%)

9 (32.1%)

 No

32 (59%)

17 (65.4%)

15 (53.6%)

Body Mass Index (BMI)

30.3 (6.5), 53

30.7 (6.8)

30.01 (6.4)

Serum Ferritin (SF) (microg/L)

66.3

(44.1)

53

64.2

(29.1)

26

68.4

(55.3)

27

Transferrin Saturation % (TSAT)

20.1 (7.4)

53

22.3 (8.8)

26

19.7 (5.6)

27

Haemoglobin (Hb) (g/L)

128.7

(10.1), 54

131

(7.4), 26

126.6

(11.8), 28

Serum Creatinine (micromol/L)

186.7

(58.6), 54

167

(40.2), 26

204.9

(67.3), 28

eGFR (ml/min/1.73m2)

31.1

(9.6), 54

33.2

(9.3), 26

29.1

(9.6), 28

Cystatin C

2.2

(0.6), 52

2.1

(0.5), 26

2.4

(0.6), 26

uACR (mg/mmol)

60.9

(133.3), 26

26.9

(40), 13

94.8

(181.4), 13

uPCR (mg/mmol)

83.8

(128.4), 40

51.9

(59.3), 19

112.7

(164.8), 21

CRP

(mg/L)

5.0

(4.4), 53

6.3

(5.5), 26

3.8

(2.4), 27

Serum Albumin (g/L)

39.8

(5.6)

40.8

(4.2)

38.8

(6.9)

Platelet count

(X105)

235

(58.9)

226

(52.4)

243

(64.1)

Phosphate

(mmol/L)

1.2

(0.2)

1.1

(0.2)

1.2

(0.2)

NT pro BNP

(ng/L)

485.2

(1268.4), 51

422.5 (881.9), 25

545.4 (1569.5), 26

PWV measurement

8.3

(3.2), 54

8.3

(2.8), 26

8.3

(3.6), 28

AiX measurement

24.2 (10.7)

54

25.4 (10.7)

26

24.1 (10.8)

28

6MWT

Metres (m)

401.2

(120.2), 52

386.6

(135.8), 25

414.7

(104.5), 27

KD-KQoL SF36

(normalised data)

40.2

(10.4), 48

40.2

(10.4), 21

40.4

(9.55), 27

MLHF

23.97

(26.3)

22.7 (25.7)

18

25.0 (27.3)

24

Systolic Blood Pressure

(mmHG)

133.6

(19.5), 54

138.2 (19.9), 26

129.4

(18.4), 28

Diastolic Blood Pressure

(mmHG)

77.3

(11.3), 54

78.5

(10.7), 26

76.2

(11.8), 28

Baseline ECG

N

38

17

21

NCS

13

8

5

ACL

1

1

0

Not Recorded

2

0

2

Diabetes

17

8

9

Hypertension

4

2

2

Polycystic Kidney Disease

5

2

3

Pyelonephritis/Reflux

3

1

2

Glomerulonephritis / IgA/vasculitis/interstitial nephritis

14

8

6

Other/unknown

11

5

6